Becton, Dickinson and Co. | BDX - Ebitda

Stock Price
159.36
Daily Change
-0.27 -0.17%
Monthly
-10.16%
Yearly
-29.48%
Q1 Forecast
154.55

Becton, Dickinson and Co. reported $1.71B in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Abbott USD 3.09B 44M Sep/2025
Agilent USD 540M 74M Sep/2025
Align Technology USD 183.84M 19.77M Sep/2025
AngioDynamics USD -369K 2.01M Feb/2025
Avanos Medical USD 10M 73.9M Sep/2025
Baxter International USD 426M 36M Sep/2025
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Bio-Rad Laboratories USD -374.6M 841.8M Sep/2025
Boston Scientific USD 1.37B 1000K Sep/2025
Cooper Companies USD 323.4M 13.2M Dec/2025
Danaher USD 2.13B 252M Dec/2025
Dentsply International USD 135M 32M Dec/2025
Dexcom USD 422.2M 53.8M Dec/2025
Edwards Lifesciences USD 464.3M 4.7M Sep/2025
Exact Sciences USD 135.42M 2.8M Sep/2025
Globus Medical USD 280.46M 27.86M Dec/2025
Hologic USD 330.4M 16.6M Dec/2025
Insulet USD 194M 34M Dec/2025
Integra LifeSciences USD 104.21M 25.76M Dec/2025
Intuitive Surgical USD 919.7M 21M Sep/2025
J&J USD 9.52B 389M Sep/2025
Masimo USD 91.9M 19.9M Sep/2025
Medtronic USD 2.93B 482M Dec/2025
Solventum Corp USD 437M 38M Dec/2025
Stryker USD 1.67B 206M Sep/2025
Tandem Diabetes Care USD 32.9M 30.13M Dec/2025
Teleflex USD -328.81M 536.43M Sep/2025
Terumo JPY 69.99B 3.22B Dec/2025
Thermo Fisher Scientific USD 3.17B 335M Dec/2025
Zimmer Biomet Holdings USD 759M 120.8M Dec/2025